A Multi-part, Double Blind Study to Assess Safety, Tolerability and Efficacy of Tropifexor (LJN452) in PBC Patients

Clinical trial NCT02516605 · COMPLETED

Trial details

NCT number: NCT02516605
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Primary Biliary Cholangitis

Start date: 2015-09-09
Primary completion: 2018-08-02
Enrollment: 61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.